GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » YoY Rev. per Sh. Growth

Chordia Therapeutics (TSE:190A) YoY Rev. per Sh. Growth : 0.00% (As of Feb. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Chordia Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Feb. 2025 was 0.00%.

Chordia Therapeutics's Revenue per Share for the three months ended in Feb. 2025 was 円0.00.

Chordia Therapeutics YoY Rev. per Sh. Growth Historical Data

The historical data trend for Chordia Therapeutics's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics YoY Rev. per Sh. Growth Chart

Chordia Therapeutics Annual Data
Trend Aug21 Aug22 Aug23 Aug24
YoY Rev. per Sh. Growth
- -100.00 - -100.00

Chordia Therapeutics Quarterly Data
Aug21 Aug22 May23 Aug23 May24 Aug24 Feb25
YoY Rev. per Sh. Growth Get a 7-Day Free Trial - - - - -

Chordia Therapeutics YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Chordia Therapeutics's YoY Rev. per Sh. Growth for the fiscal year that ended in Aug. 2024 is calculated as:

YoY Rev. per Sh. Growth (A: Aug. 2024 )
=(Revenue per Share (A: Aug. 2024 )-Revenue per Share (A: Aug. 2023 ))/ | Revenue per Share (A: Aug. 2023 ) |
=(0-44.292)/ | 44.292 |
=-100.00 %

Chordia Therapeutics's YoY Rev. per Sh. Growth for the quarter that ended in Feb. 2025 is calculated as:

YoY Rev. per Sh. Growth (Q: Feb. 2025 )
=(Revenue per Share (Q: Feb. 2025 )-Revenue per Share (Q: May. 2023 )) / | Revenue per Share (Q: May. 2023 )) |
=(0-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chordia Therapeutics YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordia Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
TSE:4978 TSE:4579 TSE:4588 TSE:4599 TSE:7776 TSE:4880 TSE:4888 TSE:7096 TSE:4583 TSE:206A VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012
Website
https://www.chordiatherapeutics.com
Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines